Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antimicrobial Proteins01:23

Antimicrobial Proteins

15.4K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
15.4K
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

79
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
79
Surface Membrane Barriers01:18

Surface Membrane Barriers

3.4K
The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
3.4K
Antifungal Agents01:15

Antifungal Agents

62
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
62
Biological Methods for Microbial Control01:28

Biological Methods for Microbial Control

1.3K
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
1.3K
iChip01:24

iChip

66
The cultivation of environmental microorganisms has long been hindered by the inability to replicate complex native conditions in vitro. The isolation chip (iChip) addresses this limitation by facilitating the growth of previously uncultivable microorganisms through in situ incubation. Designed for high-throughput microbial cultivation, the iChip comprises hundreds of microchambers, each capable of housing a single microbial cell. These microchambers are loaded with a mixture of molten agar and...
66

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bioinspired antimicrobial glass coatings for clear and infection-resistant surfaces.

Journal of materials chemistry. B·2026
Same author

Rising Stars in Infectious Diseases Research: Celebrating Our Early Career Awardees.

ACS infectious diseases·2026
Same author

Quaternized Thiomers for Antibacterial Activity and Hyperinflammation Mitigation.

ACS infectious diseases·2026
Same author

ACS @150: Role of Medicinal Chemistry in Antibacterial Drug Discovery.

ACS infectious diseases·2026
Same author

Call for Papers: Medicinal Chemistry and Pharmacology of Antiviral Drugs.

Journal of medicinal chemistry·2026
Same author

Combination Therapy: A Pillar in the Fight Against Infectious Diseases.

ACS infectious diseases·2025

Related Experiment Video

Updated: Apr 3, 2026

Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization
10:13

Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization

Published on: August 11, 2018

12.9K

Membrane-Active Small Molecules: Designs Inspired by Antimicrobial Peptides.

Chandradhish Ghosh1, Jayanta Haldar2

  • 1Chemical Biology and Medicinal Chemistry Laboratory, New Chemistry Unit, Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) Jakkur, Bengaluru 560064, Karnataka (India).

Chemmedchem
|September 20, 2015
PubMed
Summary

Antimicrobial peptides (AMPs) show promise against drug-resistant infections, but limitations exist. This review explores small molecule synthetic AMP mimics, discussing their design, activity, and future research directions.

Keywords:
antibioticsantiprotozoal agentsantiviral agentsdrug designpeptidomimetics

More Related Videos

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
11:56

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids

Published on: May 4, 2018

13.2K
Measuring Peptide Translocation into Large Unilamellar Vesicles
12:27

Measuring Peptide Translocation into Large Unilamellar Vesicles

Published on: January 27, 2012

14.3K

Related Experiment Videos

Last Updated: Apr 3, 2026

Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization
10:13

Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization

Published on: August 11, 2018

12.9K
Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
11:56

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids

Published on: May 4, 2018

13.2K
Measuring Peptide Translocation into Large Unilamellar Vesicles
12:27

Measuring Peptide Translocation into Large Unilamellar Vesicles

Published on: January 27, 2012

14.3K

Area of Science:

  • Infectious disease research
  • Drug discovery and development
  • Antimicrobial resistance

Background:

  • Infectious diseases remain a significant cause of human illness.
  • Increasing antimicrobial resistance necessitates novel therapeutic strategies.
  • Antimicrobial peptides (AMPs) are a promising class of compounds, but face development challenges.

Purpose of the Study:

  • To review the progress in developing small molecule synthetic mimics of AMPs.
  • To discuss the design principles and biological activities of these AMP mimics.
  • To identify current challenges and future research opportunities in the field.

Main Methods:

  • Comprehensive literature review of studies on synthetic AMP mimics.
  • Analysis of structural features and design strategies employed.
  • Examination of reported biological activities and mechanisms of action.

Main Results:

  • Significant advancements have been made in designing small molecules that emulate AMP properties.
  • Various structural motifs and design approaches have yielded promising antimicrobial activity.
  • Key challenges include optimizing efficacy, stability, and reducing toxicity of synthetic mimics.

Conclusions:

  • Small molecule AMP mimics represent a viable alternative to natural AMPs for combating resistant pathogens.
  • Further research is needed to address current limitations and fully exploit the therapeutic potential of these compounds.
  • Future directions include exploring novel designs, enhancing delivery systems, and conducting rigorous preclinical and clinical evaluations.